ArticleFrontiers in endocrinology2023

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer.

Yuanfa Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.